
- UCAS course code
- F152
- UCAS institution code
- M20
MChem Chemistry with Medicinal Chemistry / Course details
Year of entry: 2023
- View tabs
- View full page
Course unit details:
Synthesis for Drug Discovery and Development
Unit code | CHEM30442 |
---|---|
Credit rating | 10 |
Unit level | Level 3 |
Teaching period(s) | Semester 2 |
Offered by | Department of Chemistry |
Available as a free choice unit? | No |
Overview
This course unit detail provides the framework for delivery in 21/22 and may be subject to change due to any additional Covid-19 impact. Please see Blackboard / course unit related emails for any further updates.
Lectures and workshops from staff from the School of Chemistry, AstraZeneca and the School of Pharmacy and Pharmaceutical Sciences will discuss aspects of the drug development process.
Part 1 Array chemistry Professor David J. Procter (School of Chemistry) (8 lectures)
The course will describe multicomponent couplings for the construction of arrays of medicinally-relevant compounds. The value of the multicomponent couplings will be illustrated through examples of their application in several case studies. In addition, high-throughput methods for the synthesis of compound collections or libraries for medicinal chemistry will be described. Topics covered will include, solid-phase organic synthesis, supported reagents, combinatorial synthesis and parallel synthesis.
Part 2 Process Chemistry Dr Matthew Ball (AstraZeneca, Macclesfield) (8 lectures)
This series of lectures will focus on the role of the Process Chemist in pharmaceutical development, starting with drug discovery projects and producing kilo-lab, plant and multi-ton campaigns for established products. Using the framework of the SELECT criteria (Safety, environmental, legal, economic, control and throughput), real industrial case studies will be presented, aiming to show that there are very few areas of organic chemistry which cannot be developed at scale. This course also aims to display the importance of route evaluation and selection alongside good mechanistic and process understanding in the development of robust large-scale manufacturing processes.
Part 3 The drug development workshop Prof Leon Aarons (Pharmacy and Pharmaceutical Sciences) (6 h workshop)
Pre/co-requisites
Unit title | Unit code | Requirement type | Description |
---|---|---|---|
Fundamentals of Biochemistry | BIOL10551 | Pre-Requisite | Compulsory |
Properties of Medicines | PHAR10102 | Pre-Requisite | Compulsory |
Fundamentals of Drug Discovery | CHEM20421 | Pre-Requisite | Compulsory |
The Big Killers | PHAR20302 | Pre-Requisite | Compulsory |
Advanced Drug Discovery | CHEM30441 | Pre-Requisite | Compulsory |
Aims
The unit aims to:
1. Discuss recent advances in the synthesis of compound “arrays” for drug discovery (Part 1).
2. Study the role of the process chemist in drug development (Part 2).
3. Give an overview of drug development through an intensive workshop (Part 3).
Learning outcomes
On successful completion of the course students should be able to:
- Understand a variety of multicomponent coupling reactions for the synthesis of compound arrays.
- Appreciate the modern techniques used in medicinal chemistry for the synthesis of compound libraries for evaluation.
- Be able to apply the use of solid-supports and solid-supported reagents to solve synthetic problems.
- Have a good basic understanding of the role of the Process Chemist in converting lab scale chemistry and route concepts to the pilot plant in a safe and robust manner.
- Build on existing synthetic and mechanistic knowledge in organic chemistry, and gain an appreciation of the use of known and new chemistry and techniques in route design and selection.
- Understand the pharmaceutical industry in terms of mid to late stage development as well as the main areas of consideration on scaling reactions appropriately
Teaching and learning methods
Lectures plus a two-day drug discovery workshop taken within the School of Pharmacy
Transferable skills and personal qualities
Problem solving, time management, data handling and interpretation
Assessment methods
Method | Weight |
---|---|
Written exam | 80% |
Set exercise | 20% |
Feedback methods
Part 1 Revision problem sheet – handed in and feedback given by the Lecturer remotely or through one-to-one meetings
Part 2 Revision Workshop – feedback from interaction with Lecturer
Part 3 Drug Development Workshop – feedback from interaction with workshop staff
Study hours
Scheduled activity hours | |
---|---|
Assessment written exam | 2 |
Lectures | 16 |
Practical classes & workshops | 8 |
Independent study hours | |
---|---|
Independent study | 74 |
Teaching staff
Staff member | Role |
---|---|
David Procter | Unit coordinator |